These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18766176)

  • 1. Models from experiments: combinatorial drug perturbations of cancer cells.
    Nelander S; Wang W; Nilsson B; She QB; Pratilas C; Rosen N; Gennemark P; Sander C
    Mol Syst Biol; 2008; 4():216. PubMed ID: 18766176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbation biology: inferring signaling networks in cellular systems.
    Molinelli EJ; Korkut A; Wang W; Miller ML; Gauthier NP; Jing X; Kaushik P; He Q; Mills G; Solit DB; Pratilas CA; Weigt M; Braunstein A; Pagnani A; Zecchina R; Sander C
    PLoS Comput Biol; 2013; 9(12):e1003290. PubMed ID: 24367245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks.
    Martin F; Thomson TM; Sewer A; Drubin DA; Mathis C; Weisensee D; Pratt D; Hoeng J; Peitsch MC
    BMC Syst Biol; 2012 May; 6():54. PubMed ID: 22651900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting bioprocess targets of chemical compounds through integration of chemical-genetic and genetic interactions.
    Simpkins SW; Nelson J; Deshpande R; Li SC; Piotrowski JS; Wilson EH; Gebre AA; Safizadeh H; Okamoto R; Yoshimura M; Costanzo M; Yashiroda Y; Ohya Y; Osada H; Yoshida M; Boone C; Myers CL
    PLoS Comput Biol; 2018 Oct; 14(10):e1006532. PubMed ID: 30376562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models.
    Martin F; Sewer A; Talikka M; Xiang Y; Hoeng J; Peitsch MC
    BMC Bioinformatics; 2014 Jul; 15():238. PubMed ID: 25015298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix trace operators: from spectral moments of molecular graphs and complex networks to perturbations in synthetic reactions, micelle nanoparticles, and drug ADME processes.
    Gonzalez-Diaz H; Arrasate S; Juan AG; Sotomayor N; Lete E; Speck-Planche A; Ruso JM; Luan F; Cordeiro MN
    Curr Drug Metab; 2014; 15(4):470-88. PubMed ID: 25204825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic gene network modelling identified new regulatory mechanisms in HCV infection.
    Popik OV; Petrovskiy ED; Mishchenko EL; Lavrik IN; Ivanisenko VA
    Virus Res; 2016 Jun; 218():71-8. PubMed ID: 26481968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel recurrent neural network for modelling biological networks: oscillatory p53 interaction dynamics.
    Ling H; Samarasinghe S; Kulasiri D
    Biosystems; 2013 Dec; 114(3):191-205. PubMed ID: 24012741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inference of signaling and gene regulatory networks by steady-state perturbation experiments: structure and accuracy.
    Andrec M; Kholodenko BN; Levy RM; Sontag E
    J Theor Biol; 2005 Feb; 232(3):427-41. PubMed ID: 15572066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbation biology links temporal protein changes to drug responses in a melanoma cell line.
    Nyman E; Stein RR; Jing X; Wang W; Marks B; Zervantonakis IK; Korkut A; Gauthier NP; Sander C
    PLoS Comput Biol; 2020 Jul; 16(7):e1007909. PubMed ID: 32667922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.
    Korkut A; Wang W; Demir E; Aksoy BA; Jing X; Molinelli EJ; Babur Ö; Bemis DL; Onur Sumer S; Solit DB; Pratilas CA; Sander C
    Elife; 2015 Aug; 4():. PubMed ID: 26284497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
    Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
    J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding complex biological networks - tracing essential and modulatory parameters in complex and simplified models of the cell cycle.
    Eriksson O; Andersson T; Zhou Y; Tegnér J
    BMC Syst Biol; 2011 Aug; 5():123. PubMed ID: 21819620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
    Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
    BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Molecular-Cellular Network Cancer Theory: A Systems Biology Approach.
    Wang G; Yuan R; Zhu X; Ao P
    Methods Mol Biol; 2018; 1702():215-245. PubMed ID: 29119508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning signaling networks from combinatorial perturbations by exploiting siRNA off-target effects.
    Tiuryn J; Szczurek E
    Bioinformatics; 2019 Jul; 35(14):i605-i614. PubMed ID: 31510678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering Combinatorial Genetics.
    Wong AS; Choi GC; Lu TK
    Annu Rev Genet; 2016 Nov; 50():515-538. PubMed ID: 27732793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.